NFKB1 and neoplasm: RELA (NF-κB p65) (HR = 1.6, p = 0.0055) has been linked to inflammatory processes and has been shown to contribute to immune suppression and chemotherapy resistance in the tumor microenvironment through the activation of NF-κB signaling pathways.